ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
88.01
-2.22 (-2.46%)
At close: Oct 23, 2026, 4:00 PM EDT
87.56
-0.45 (-0.51%)
After-hours: Oct 23, 2026, 7:56 PM EDT
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of $7.49 billion as of October 23, 2026. Its market cap has increased by 12.22% in one year.
Market Cap
7.49B
Enterprise Value
7.04B
1-Year Change
12.22%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from $225.47M to $7.49B, an increase of 3,223.67%. That is a compound annual growth rate of 36.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 7.68B | -30.17% |
| Dec 31, 2025 | 11.00B | 2,382.10% |
| Dec 31, 2024 | 443.27M | -34.81% |
| Dec 29, 2023 | 679.99M | 513.79% |
| Dec 30, 2022 | 110.78M | -79.15% |
| Dec 31, 2021 | 531.29M | -8.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Protagonist Therapeutics | 9.03B |
| Caris Life Sciences | 8.96B |
| ImmunityBio | 8.81B |
| Cytokinetics | 8.67B |
| Spyre Therapeutics | 8.63B |
| Twist Bioscience | 8.49B |
| Arrowhead Pharmaceuticals | 8.24B |
| Axsome Therapeutics | 8.18B |